Jinying Zhao

Dr. Jinying Zhao

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Neurobiology of Aging
Verified
Journal Article
Closed access
ZHZhiguang Huo
Zhiguang Huo
LYLei Yu
Lei Yu
JYJingyun Yang
Jingyun Yang
YZYun Zhu
Yun Zhu
DBDavid A. Bennett
David A. Bennett
JZJinying Zhao
Jinying Zhao

2 September 2019 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
YZYun Zhu
Yun Zhu
ESEric Strachan
Eric Strachan
EFEmily Fowler
Emily Fowler
TBTamara Bacus
Tamara Bacus
PRPeter Roy-Byrne
Peter Roy-Byrne
JZJinying Zhao
Jinying Zhao
DNA methylation plays an important role in major depressive disorder (MDD), but the specific genes and genomic regions associated with MDD remain largely unknown. Here we conducted genome-wide profiling of DNA methylation (Infinium MethylationEPIC BeadChip) and gene expression (RNA-seq) in peripheral blood monocytes from 79 monozygotic twin pairs (mean age 38.2 ± 15.6 years) discordant on lifetime history of MDD to identify differentially methylated regions (DMRs) and differentially expressed genes (DEGs) associated with MDD, followed by replication in brain tissue samples. Integrative DNA methylome and transcriptome analysis and network analysis was performed to identify potential functional epigenetic determinants for MDD. We identified 39 DMRs and 30 DEGs associated with lifetime history of MDD. Some genes were replicated in postmortem brain tissue. Integrative DNA methylome and transcriptome analysis revealed both negative and positive correlations between DNA methylation and gene expression, but the correlation pattern varies greatly by genomic locations. Network analysis revealed distinct gene modules enriched in signaling pathways related to stress responses, neuron apoptosis, insulin receptor signaling, mTOR signaling, and nerve growth factor receptor signaling, suggesting potential functional relevance to MDD. These results demonstrated that altered DNA methylation and gene expression in peripheral blood monocytes are associated with MDD. Our results highlight the utility of using peripheral blood epigenetic markers and demonstrate that a monozygotic discordant co-twin control design can aid in the discovery of novel genes associated with MDD. If validated, the newly identified genes may serve as novel biomarkers or druggable targets for MDD and related disorders.

5 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZHZixin Hu
Zixin Hu
RJRong Jiao
Rong Jiao
PWPanpan Wang
Panpan Wang
YZYun Zhu
Yun Zhu
JZJinying Zhao
Jinying Zhao
MXMomiao Xiong
Momiao Xiong
Although Alzheimer’s disease (AD) is a central nervous system disease and type 2 diabetes MELLITUS (T2DM) is a metabolic disorder, an increasing number of genetic epidemiological studies show clear link between AD and T2DM. The current approach to uncovering the shared pathways between AD and T2DM involves association analysis; however such analyses lack power to discover the mechanisms of the diseases. As an alternative, we developed novel causal inference methods for genetic studies of AD and T2DM and pipelines for systematic multi-omic casual analysis to infer multilevel omics causal networks for the discovery of common paths from genetic variants to AD and T2DM. The proposed pipelines were applied to 448 individuals from the ROSMAP Project. We identified 13 shared causal genes, 16 shared causal pathways between AD and T2DM, and 754 gene expression and 101 gene methylation nodes that were connected to both AD and T2DM in multi-omics causal networks.

19 January 2023 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
GMGuanhong Miao
Guanhong Miao
JDJason Deen
Jason Deen
JSJoseph B. Struzeski
Joseph B. Struzeski
MCMingjing Chen
Mingjing Chen
YZYing Zhang
Ying Zhang
JZJinying Zhao
Jinying Zhao

1 April 2019 in Neurobiology of Aging
Verified
Journal Article
Closed access
ZHZhiguang Huo
Zhiguang Huo
YZYun Zhu
Yun Zhu
LYLei Yu
Lei Yu
JYJingyun Yang
Jingyun Yang
PJPhilip De Jager
Philip De Jager
JZJinying Zhao
Jinying Zhao

1 December 2021 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
GMGuanhong Miao
Guanhong Miao
YZYing Zhang
Ying Zhang
ZHZhiguang Huo
Zhiguang Huo
WZWenjie Zeng
Wenjie Zeng
JZJianhui Zhu
Jianhui Zhu
JZJinying Zhao
Jinying Zhao
OBJECTIVE: Comprehensive assessment of alterations in lipid species preceding type 2 diabetes (T2D) is largely unknown. We aimed to identify plasma molecular lipids associated with risk of T2D in American Indians.RESEARCH DESIGN AND METHODS: Using untargeted liquid chromatography–mass spectrometry, we repeatedly measured 3,907 fasting plasma samples from 1,958 participants who attended two examinations (∼5.5 years apart) and were followed up to 16 years in the Strong Heart Family Study. Mixed-effects logistic regression was used to identify lipids associated with risk of T2D, adjusting for traditional risk factors. Repeated measurement analysis was performed to examine the association between change in lipidome and change in continuous measures of T2D, adjusting for baseline lipids. Multiple testing was controlled by false discovery rate at 0.05.RESULTS: Higher baseline level of 33 lipid species, including triacylglycerols, diacylglycerols, phosphoethanolamines, and phosphocholines, was significantly associated with increased risk of T2D (odds ratio [OR] per SD increase in log2-transformed baseline lipids 1.50–2.85) at 5-year follow-up. Of these, 21 lipids were also associated with risk of T2D at 16-year follow-up. Aberrant lipid profiles were also observed in prediabetes (OR per SD increase in log2-transformed baseline lipids 1.30–2.19 for risk lipids and 0.70–0.78 for protective lipids). Longitudinal changes in 568 lipids were significantly associated with changes in continuous measures of T2D. Multivariate analysis identified distinct lipidomic signatures differentiating high- from low-risk groups.CONCLUSIONS: Lipid dysregulation occurs many years preceding T2D, and novel molecular lipids (both baseline level and longitudinal change over time) are significantly associated with risk of T2D beyond traditional risk factors. Our findings shed light on the mechanisms linking dyslipidemia to T2D and may yield novel therapeutic targets for early intervention tailored to American Indians.